Therefore CPT inhibits the invasion and migration of breast cancer cells by inhibiting the PKM2/β-catenin axis in both ERα-positive and -negative breast cancer cell lines (Zhou et al., 2020). This evidence concerns the gene ESR1 and breast carcinoma.